Lepzi

Lepzi is a global point-of-care medical diagnostics company that designs, develops, and markets rapid and reliable tests for near-patient use. Its easy-to-use and cost-effective reader platforms allow faster results in primary care settings as well as in clinics and hospitals.

＞MORE ABOUT LEPZI

Women’s Health

Cardiovascular and Pulmonary Diseases

Infectious Disease and Inflammation

Tumor Markers and Drug Abuse

Readers

Lepzi Immunofluorescence Platform

No sample dilution and no liquid reagents!

Lepzi Immunochromatography Platform

Rapid, accurate and convenient!

Lepzi Immunofluorescence Platform

No sample dilution and no liquid reagents!

Lepzi Immunochromatography Platform

Rapid, accurate and convenient!

From global priorities to point-of-care conversations: Lepzi at SMFM 2026

The SMFM 2026 Global Congress in Utrecht brought together maternal health professionals and researchers from around the world. For Lepzi, it was an opportunity to share its research and hear how clinicians are thinking about access to pre-eclampsia assess

SPARK-PE Pre-Validation Visit at St Thomas’ Hospital

WE ARE EXCITED TO PARTICIPATE AT SMFM 2026

MEET US AT SMFM 2026 GLOBAL CONGRESS

Lepzi has been awarded a grant to advance development of next-generation PLGF and sFlt-1 tests to aid in the diagnosis of preeclampsia

Pioneering next-generation diagnostics for safer pregnancies.

Point-of-Care Placental Growth Factor for Predicting Adverse Outcomes in Sierra Leo

Hypertension (American Heart Association)

World Pre-eclampsia Day Webinar

22 May 2025 Una Health in collaboration with Action on Pre-eclampsia (APEC)

New Publication in Pregnancy Hypertension Journal – Lepzi PLGF Study

We are proud to share the results of our recently published study on the Lepzi® PLGF test, now featured in Pregnancy Hypertension.

XXV National Gynecologic Conference

23-26. March 2023 Rila Hotel, Borovets, Bulgaria

XXIV National Congress of Infertility and Reproductive Health with International Participation

06-09. April 2023 Rila Hotel, Borovets, Bulgaria

BULMEDICA · BULDENTAL · DERMA & AESTHETICS

31. May - 02. June 2023 Inter Expo Center, Sofia, Bulgaria

From global priorities to point-of-care conversations: Lepzi at SMFM 2026

The SMFM 2026 Global Congress in Utrecht brought together maternal health professionals and researchers from around the world. For Lepzi, it was an opportunity to share its research and hear how clinicians are thinking about access to pre-eclampsia assess

SPARK-PE Pre-Validation Visit at St Thomas’ Hospital

WE ARE EXCITED TO PARTICIPATE AT SMFM 2026

MEET US AT SMFM 2026 GLOBAL CONGRESS

Lepzi has been awarded a grant to advance development of next-generation PLGF and sFlt-1 tests to aid in the diagnosis of preeclampsia

Pioneering next-generation diagnostics for safer pregnancies.

Point-of-Care Placental Growth Factor for Predicting Adverse Outcomes in Sierra Leo

Hypertension (American Heart Association)

World Pre-eclampsia Day Webinar

22 May 2025 Una Health in collaboration with Action on Pre-eclampsia (APEC)

New Publication in Pregnancy Hypertension Journal – Lepzi PLGF Study

We are proud to share the results of our recently published study on the Lepzi® PLGF test, now featured in Pregnancy Hypertension.

XXV National Gynecologic Conference

23-26. March 2023 Rila Hotel, Borovets, Bulgaria

XXIV National Congress of Infertility and Reproductive Health with International Participation

06-09. April 2023 Rila Hotel, Borovets, Bulgaria

BULMEDICA · BULDENTAL · DERMA & AESTHETICS

31. May - 02. June 2023 Inter Expo Center, Sofia, Bulgaria

＞MORE ABOUT LEPZI

Lepzi Immunofluorescence Platform

Lepzi Immunochromatography Platform

Lepzi Immunofluorescence Platform

Lepzi Immunochromatography Platform

From global priorities to point-of-care conversations: Lepzi at SMFM 2026

SPARK-PE Pre-Validation Visit at St Thomas’ Hospital

WE ARE EXCITED TO PARTICIPATE AT SMFM 2026

Lepzi has been awarded a grant to advance development of next-generation PLGF and sFlt-1 tests to aid in the diagnosis of preeclampsia

Point-of-Care Placental Growth Factor for Predicting Adverse Outcomes in Sierra Leo

World Pre-eclampsia Day Webinar

New Publication in Pregnancy Hypertension Journal – Lepzi PLGF Study

XXV National Gynecologic Conference

XXIV National Congress of Infertility and Reproductive Health with International Participation

BULMEDICA · BULDENTAL · DERMA & AESTHETICS

From global priorities to point-of-care conversations: Lepzi at SMFM 2026

SPARK-PE Pre-Validation Visit at St Thomas’ Hospital

WE ARE EXCITED TO PARTICIPATE AT SMFM 2026

Lepzi has been awarded a grant to advance development of next-generation PLGF and sFlt-1 tests to aid in the diagnosis of preeclampsia

Point-of-Care Placental Growth Factor for Predicting Adverse Outcomes in Sierra Leo

World Pre-eclampsia Day Webinar

New Publication in Pregnancy Hypertension Journal – Lepzi PLGF Study

XXV National Gynecologic Conference

XXIV National Congress of Infertility and Reproductive Health with International Participation

BULMEDICA · BULDENTAL · DERMA & AESTHETICS

CONTACT US